This supplement reviews two posters presented at the ‘Liver Meeting®’ 2021. Both posters delved into new trial data on the efficacy of Aramchol™ to treat non-alcoholic steatohepatitis, analysing biopsy outcomes, fibrosis improvement, and biomarker data.
EMJ Hepatology 10 [Supplement 1] . 2022
January 2022
In this issue
Rate this content's potential impact on patient outcomes
Average rating / 5. Vote count:
No votes so far! Be the first to rate this content.
Thank you!
Please share some more information on the rating you have given